Data as of:
Price 02-03-26 16:00 ET,
Balance Sheet 2025-09-30,
Income Statement 2025-09-30,
Cash Flow 2025-09-30
Indicators
Dividend indicators
Value
Date
Pays Dividend
No
2-1-2026
Last Dividend Date
11-7-19
Income indicators
Value
Date
EBITDA Positive
No
2-1-2026
Net Income Positive
No
2-1-2026
Avg CA Burn (Annual %)
-23.96%
2-1-2026
Avg CA Burn (Quarterly %)
-2.69%
2-1-2026
Shares Outstanding Changes
Date
Shares Outstanding
Delta
2025-09-18
1,859,123
+3
Short Interest Changes
Latest short interest:
172,610 shares
(12.47% of float)
| Days to cover: 0.05
Date
Short Interest
Delta
Δ %
2026-02-03
172,610 shares
+0
+0.00%
2026-02-02
172,610 shares
+0
+0.00%
2026-01-30
172,610 shares
None
—
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
Date
Volume
Shares Outstanding
Volume / Shares
Price
2026-02-02
1,142,880
1,859,123
61.47%
$1.40
2026-01-30
1,993,855
1,859,123
107.25%
$1.27
2026-01-28
573,741
1,859,123
30.86%
$1.32
2026-01-26
514,130
1,859,123
27.65%
$1.55
2026-01-23
1,223,042
1,859,123
65.79%
$1.62
2026-01-22
1,380,922
1,859,123
74.28%
$1.62
2026-01-21
11,658,278
1,859,123
627.08%
$1.89
2026-01-20
6,090,496
1,859,123
327.60%
$4.45
2026-01-16
306,252,685
1,859,123
16472.97%
$8.00
2026-01-15
7,102,371
1,859,123
382.03%
$1.43
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.